BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12771804)

  • 1. Phosphoinositide signaling in urological disease.
    Theodorescu D
    J Urol; 2003 Jun; 169(6):2394-6. PubMed ID: 12771804
    [No Abstract]   [Full Text] [Related]  

  • 2. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
    Paez J; Sellers WR
    Cancer Treat Res; 2003; 115():145-67. PubMed ID: 12613196
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling.
    Ott VL; Cambier JC
    Semin Immunol; 2002 Feb; 14(1):1-6. PubMed ID: 11884225
    [No Abstract]   [Full Text] [Related]  

  • 4. PI3K/Akt and apoptosis: size matters.
    Franke TF; Hornik CP; Segev L; Shostak GA; Sugimoto C
    Oncogene; 2003 Dec; 22(56):8983-98. PubMed ID: 14663477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PTEN expression in endometrial cancer and the prognosis].
    Kanamori Y; Uegaki K; Kigawa J; Terakawa N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
    [No Abstract]   [Full Text] [Related]  

  • 6. [Involvement of phosphoinositide 3-kinases and phosphoinositide phosphatases in immune responses, glucose metabolism and tumorigenesis].
    Sasaki T; Sasaki J; Suzuki A; Penninger JM
    Tanpakushitsu Kakusan Koso; 2001 Sep; 46(12):1820-9. PubMed ID: 11552264
    [No Abstract]   [Full Text] [Related]  

  • 7. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.
    Vazquez F; Sellers WR
    Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987
    [No Abstract]   [Full Text] [Related]  

  • 9. Pleiotropic effects of statins: acutely good, but chronically bad?
    Schulz R
    J Am Coll Cardiol; 2005 Apr; 45(8):1292-4. PubMed ID: 15837264
    [No Abstract]   [Full Text] [Related]  

  • 10. An essential role for protein synthesis in oncogenic cellular transformation.
    Bader AG; Vogt PK
    Oncogene; 2004 Apr; 23(18):3145-50. PubMed ID: 15094764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
    Kandasamy K; Srivastava RK
    Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells.
    Van de Sande T; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Cancer Res; 2002 Feb; 62(3):642-6. PubMed ID: 11830512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
    Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
    Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pten, a protean tumor suppressor.
    Mutter GL
    Am J Pathol; 2001 Jun; 158(6):1895-8. PubMed ID: 11395362
    [No Abstract]   [Full Text] [Related]  

  • 16. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.
    She QB; Solit DB; Ye Q; O'Reilly KE; Lobo J; Rosen N
    Cancer Cell; 2005 Oct; 8(4):287-97. PubMed ID: 16226704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conserved PI3'K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila.
    Scanga SE; Ruel L; Binari RC; Snow B; Stambolic V; Bouchard D; Peters M; Calvieri B; Mak TW; Woodgett JR; Manoukian AS
    Oncogene; 2000 Aug; 19(35):3971-7. PubMed ID: 10962553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling.
    Chuenkova MV; Furnari FB; Cavenee WK; Pereira MA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9936-41. PubMed ID: 11481434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells.
    Nielsen-Preiss SM; Silva SR; Gillette JM
    J Cell Biochem; 2003 Dec; 90(5):964-75. PubMed ID: 14624456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation.
    Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK
    Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.